신경내분비종양은 소마토스타틴 수용체의 발현이 증가되어 있다. 소마토스타틴 수용체를 표적으로 하는 소마토스타틴 유사체 옥트레오티드는 오랫동안 신경내분비종양의 기능을 억제하는 치료제로 사용되어 왔다. 옥트레오티드에 핵의학 영상용 방사성동위원소 In-111을 표지하여 환자에 주사한 후 감마카메라로 전신을 촬영하는 기능적 핵의학 영상 또한 오래전부터 사용되었다. 최근에는 옥트레오티드 유사체에 양전자단층촬영(positron emission tomography, PET)용 방사성동위원소를 표지하여 PET/CT를 촬영하게 되었는데 기존 In-111 옥트레오스캔보다 더 선명한 영상을 얻을 수 있다. 나아가 옥트레오티드 유사체에 치료용 방사성핵종을 표지하여 주사하면 신경내분비종양의 전이된 병소를 찾아가서 방사선 치료를 하는 일명 방사선 미사일 치료가 개발되었다. 이는 펩타이드 수용체를 표적으로 하는 핵의학 치료의 일종으로 펩타이드 수용체 방사성핵종 치료(peptide receptor radionuclide therapy, PRRT)라고 한다. 같은 소마토스타틴 수용체 표적 펩타이드를 이용하여 치료 전 기능 영상을 얻어서 PRRT의 대상 환자를 선별할 수 있어 환자 개인맞춤 정밀치료가 가능하다. 또한 Lu-177과 같은 영상용 감마선과 치료용 베타선을 동시에 방출하는 방사성동위원소를 표지하면 치료와 동시에 감마카메라 영상을 얻을 수 있어 주사한 표적치료제의 분포를 매 치료마다 평가할 수 있어 진단과 치료의 합성어인 테라노스틱스가 가능하다.

NRPS (non-ribosomal pepetide synthetase) plays an important role in the biosynthesis of secondary metabolites, which includes economically important compounds such as antibiotics, antitumor agents, immune-suppressants, siderophores, toxins, etc. In most cases, however, their functions and biosynthesizing pathways have been still remained riddles because of their cryptic expression and recalcitrant genetics. In our previous genome analyses of Cordyceps bassiana C101, we predicted the sequences of secondary metabolite biosynthesizing gene clusters, which contain non-ribosomal pepetide synthetases whose functions are already known such as beauvericin, bassianolide, bassiatin, tenellin, beauverolides, and oosporein. The authors focused on nrps6 that has not been functionally studied. The single-gene deletion and overexpression mutants were established via Agrobacterium-mediated transformations. PCR, quantitative real-time PCR, and southern blot analyses were carried out to confirm the correct single-gene integrated homologous recombination. In further study, comparative metabolic profiling between wild-type and mutant strains will be followed by their detailed chemical structure analysis through NMR spectroscopy.

The aim of this study was to investigate and development collagen peptide materials from skate skin. Protein and fat content of collagen peptide showed about 95% and 0.1%, respectively. Average molecular weight of collagen peptide was measured as 1,015. In the analysis of amino acid, glycine and hydroxy proline content in collagen peptide was 19.32% and 16.25%, respectively, showing a typical characteristics of the collagen peptide. In obese db/db mice ingested 500 mg/day of collagen peptide for 18 days, the amounts of food and water intake were decreased considerably, contents of triglyceride, total cholesterol were decreased significantly in white adipose tissue of db/db mice. The final yield of collagen peptide was 17.23% in the optimized process for mass production. These results indicate that collagen peptide from skate skin may serve as candidates of fat reduction in adipose tissue and could be used as functional food and cosmetic ingredients.